HOW RUTGERS, PHARMA AND NEW JERSEY ARE JOINING FORCES TO BRING CUTTING-EDGE HEALTH CARE TO PATIENTS FASTER
HOW RUTGERS, PHARMA AND NEW JERSEY ARE JOINING FORCES TO BRING CUTTING-EDGE HEALTH CARE TO PATIENTS FASTER
How can New Jersey spark more scientific and medical breakthroughs while shortening the time it takes for those breakthroughs to reach patients? On Dec. 5, 2019, state leaders from higher education, research, policy, government and the pharmaceutical industry will meet at Rutgers University to discuss how industry, government and academia are partnering to improve clinical research in New Jersey and provide cutting-edge care to its residents.
The National Institutes of Health recently awarded $33 million to a Rutgers-led team that includes Princeton University and the New Jersey Institute of Technology to transform the way clinical research is translated into evidence-based patient care in New Jersey. For New Jerseyans, that means not having to leave their home state to access the newest clinical trials and effective therapies. The award will also help build partnerships between the three universities and the state’s huge health care and pharmaceutical industries to shorten the time it takes for innovative treatments to get to market.
The event will explore the ongoing revolution in clinical and translation science and how the government, health care industry and universities can collaborate to improve health in New Jersey.
WHEN: Dec. 5, 2019, 8:30 a.m. to 1:30 p.m.
WHERE: Livingston Student Center, 84 Joyce Kilmer Avenue, Piscataway.
SPEAKERS:
- Robert Barchi, President, Rutgers University
- Barry Ostrowsky, President and CEO, RWJBarnabas Health
- Brian Strom, Chancellor, Rutgers Biomedical and Health Sciences
- Reynold Panettieri, Vice Chancellor for Translational Medicine and Science Director, Rutgers Institute for Translational Medicine and Science
- Christopher Molloy, Chancellor, Rutgers–New Brunswick
- Dawn Furey, Vice President and Head of Portfolio Delivery Operations, Janssen Research and Development
- Jim Gunton, MBA, Tech Council Ventures
- Joachim Kohn, PhD, Rutgers professor and entrepreneur
- Rob Kowalski, PharmD, Global Head of Regulatory Affairs, US Head Development, Global Drug Development, Novartis
- Joel Cantor, Director, Center for State Health Policy
- Cathleen Bennett, President and CEO of the New Jersey Hospital Association and former Commissioner of the New Jersey Department of Health.
- Heather Howard, J.D., Lecturer in Public Affairs, Princeton University and former Commissioner of the New Jersey Department of Health and Senior Services
- Nancy Pinkin, New Jersey Assemblywoman, 18th District, and Vice-Chair of the Health and Senior Services Committee
MORE ABOUT THE GRANTS:
Rutgers-Led Team Awarded $29 Million NIH Grant for Statewide Translational Research Institute
Rutgers Receives $4 Million as New Hub to Accelerate Development of Biomedical Technologies
